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INTRODUCTION 
All product development and optimization involves 
experimentation. An interesting question is how to make 
this experimentation achieve the stated objective as 
accurately and efficiently as possible considering critical 
quality attributes of product in short time. The traditional 
approach of optimizing a formulation or process 
essentially entails studying the influence of the 
corresponding composition and process variables by 
changing single variable or factor at a Time, while 
keeping others as constant. This technique, known as 
OVAT i.e., One Variable at a Time 1, 2, 3. This approach 
involves large number of experiments with little gain of 
information on considered factors. One more 
disadvantage of this approach is interactions between the 
factors cannot be studied which may lead to 
misinterpretation of results at the final stage of product 
development. This leads to application of „Design of 
experiments‟. Table 1 shows pros of using DoE approach 
in optimizing drug delivery systems. 
Design of experiments (DoE) was invented by Ronald A. 
Fisher in the 1920s and 1930s at Rothamsted 
Experimental Station, an agricultural research station 25 
miles north of London. In Fisher‟s first book on design 
of experiments 4, 5 he showed, how valid conclusions 
could be drawn efficiently from experimentss with 
natural fluctuations such as temperature, soil conditions, 
and rain fall, that is, in the presence of nuisance 
variables. The application of DoE optimization 
techniques invariably covers use of experimental tools 
and generation of mathematical equations and graphic 
outcomes, thus illustrating a complete effect of 
considered variables on responses 6, 7, 8. Further in 
contrast to traditional approach, DoE approach reveals 
complete information with respect to factors and their 
interactions on considered responses with real 
mathematical correlation.  
FUNDAMENTAL PRINCIPLES 
The fundamental principles in design of experiments are 
solutions to the problems in experimentation which serve 
to improve the efficiency of experiments. Those 
fundamental principles are listed in Table No 2 
 
 
 
ABSTRACT 
Statistical modeling and experimental design are essential tools in field of drug delivery during product development and can 
be divided into formula and process optimization. Experimental design allows efficient experimentation in which all or a large 
subset of factors are together varied over a set of experiments, in contrast to the traditional approach of varying only one 
variable at time (OVAT). Good estimates for the required composition, geometry, dimensions and preparation procedure of 
various types of delivery systems will be available, taking into account the desired administration route, drug dose and release 
profile. Thus, the number of required experimental studies during product development can be significantly reduced, saving 
time and reducing costs. The present review discusses types of designs and methodologies used recently in academic as well as  
industrial research for optimization of novel drug delivery systems. 
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Table 1: Pros of DoE approaches over OVAT 
Formulation and process variables can be studied independently as well as in combination 
Optimization can be done in short period of time with saving cost 
Require fewer experiments  
Large number of variables can be studied with fewer experiments   
RSM designs gives detailed information about interactions between considered variables 
Lead to comprehensive understanding of the formulation system. 
Help to understand significant and insignificant factors  
Yield the “best solution” in the presence of competing objectives. 
Shows complete mathematical correlation for studied factors on responses 
Establishing and maintaining quality control 
Designing robust products 
 
Table 2: Fundamental Principles for DoE 
Principles Description Reference 
Independent Variables 
/Factors 
Affects system directly. The may be Numeric as concentration of polymer, 
milling speed, time etc. or Categorical as type of polymer, excipient etc. 
[8,9,10] 
Dependent Variables/  
Responses 
These are the measured properties of the system to estimate the outcome of 
the experiment e.g. drug release at 10 min, impurity level etc. 
Randomization 
A method that protects against an unknown bias distorting the results of the 
experiment 
[11,12] 
Replication 
Replication increases the sample size and is a method for increasing the 
precision of the experiment. 
[13] 
Blocking 
Blocking is a method for increasing precision by removing the effect of 
known factors 
[14] 
Orthogonality 
It is used if the estimated effects are due to the main factor of interest and 
are independent of interactions 
[15] 
Confounding 
It is a bias that must be controlled by suitable selection of the design and 
data analysis. 
[16] 
Resolution 
It is the ability to describe the degree to which the estimated main effects are 
aliased 
[13] 
 
EXPERIMENTAL DESIGNS 
There are a number of types of experimental designs. 
Various commonly employed experimental designs for 
RSM, screening, and factor-influence studies in 
pharmaceutical product and process development are 
 Central composite designs 
 Box–Behnken designs 
 Factorial designs 
 Plackett–Burman designs 
 
A . RESPONSE SURFACE METHODOLOGY 
The impact of each variable can be assessed by varying 
each variable while keeping others constant. However, it 
fails to take into account the interactions between these 
factors. Response surface methodology (RSM) is a 
suitable experimental design strategy to overcome this 
problem. Using RSM, the influence of the selected 
variables on the subject responses in a defined 
experimental region can be predicted by constructing 
mathematical models. The goodness of fit of the obtained 
mathematical models can be checked by statistical 
analysis. Therefore, RSM is a combination of 
mathematical and statistical techniques to analyze 
models and achieve the goal of optimizing the responses.  
Basically, the RSM can be classified into two categories:  
 Box–Wilson central composite designs (CCD) 
 Box–Behnken designs.  
CCD is composed by the factorial experiment, axial 
points and center point. This structure makes it have a 
better prediction capability than the Box–Behnken 
design. These designs have been successfully used to 
optimize the technology and drug delivery systems such 
as sustained-release tablets, Liposomes, microspheres, 
nanoparticles in recent years. 
Various examples of studies using response surface 
methodology are given in Table 3 along with details of 
study, design type and Inference of statistical 
optimization. Readers are advised to refer respective 
References for detailed study. 
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Table 3. Examples of Studies using Response Surface Methodology 
S. 
No. 
Delivery 
System 
Details of Study Design Type Inference Ref. 
1 
Self micro-
emulsion 
A two-factor, five-level CCD was undertaken to investigate the 
main effects and the interactions of the two factors on the four 
responses. The formulation variables considered for optimization 
were oil percentage (10–50%) and Sur/Co-s ratio (1–4) to study 
effect on the response variables Droplet size, Polydispersity 
index, Equilibrium solubility and Intestinal absorption rate. 
Furthermore, the desirability function approach was used to 
simultaneously optimize the responses. 
Central 
composite 
designs 
 
It was observed that Polydispersity, Droplet size, 
Equilibrium Solubility and Intestinal absorption rate was 
significantly influenced by the oil percentage, whereas 
Sur/Co-surfactant ratio was of low significance for 
Polydispersity and Droplet size and Equilibrium solubility. 
 
17 
2 
Oro-
Dispersible 
Tablets 
The author describe the application of a two factor, three level 
(32) face centered, central composite design to investigate  in-
process parameters for fast disintegrating orodispersible tablets. 
In process variables considered for optimization was tablet 
diameter and compression force (CF) to determine effect on 
Hardness, Disintegration Time (DT) and Porosity of Tablets. 
Face 
centered 
central 
composite 
design 
The study concludes that compression force and tablet 
diameter was observed to have profound and interactive 
effect on the characteristics of orodispersible tablets. The 
negative value of regression coefficient for tablet diameter 
showed an inverse relationship with hardness and DT. A 
positive value of regression coefficient for CF indicated an 
increase in Hardness and DT with increasing CF as a result 
of the decrease in tablet porosity. 
18 
3 
Nano 
suspension for 
Tablet 
 
Spray drying experiments of an itraconazole nanosuspension were 
conducted to generate a dry nanocrystal powder which was 
subsequently formulated into a tablet formulation for direct 
compression. 
 
Central Composite Design employed to identify the optimal drug-
to-excipient ratio (Mannitol: Itraconazole ratio 3:1–5:1) and inlet 
temperature (110–130⁰C) on the particle size of spray-dried 
Itraconazole nanosuspension after redispersion. Further effect of 
talc (1–3%) and magnesium stearate (0.2–1%) mass ratio was 
investigated on the properties such as angle of repose and tablet 
hardness of the formulation. 
Central 
composite 
design 
From study it was observed that the spray drying of a 
nanosuspension with a mannitol-to-drug mass ratio of 1:1 
and at an inlet temperature of 120⁰C resulted in a dry powder 
with the smallest increase in particle size. 
The angle of repose was not markedly affected by the change 
in the concentration of magnesium stearate but tablet 
hardness decreased significantly with increase in 
concentration.  For talc an increase in talc concentration 
resulted in a gradual decrease of the angle of repose and with 
no effect on compressibility of tablets. 
19 
4 
Effervescent 
Tablet 
 
Strategy is to optimize and evaluate the effects of lubricants and 
compression force on the physical characteristics of effervescent 
tablets. Residual force, crushing strength and disintegration time 
are considered as response variables with factors as concentration 
of l-leucine, polyethylene glycol and the compression force. 
A rotatable 
central 
composite 
design 
Study concludes that increasing amounts of l-leucine, 
showing good lubricating properties, reduce the crushing 
strength and prolong tablet disintegration time. 
20 
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S. 
No. 
Delivery 
System 
Details of Study Design Type Inference Ref. 
5 
Orally 
disintegrating 
tablets 
CCF design was applied to study the influence of formulation 
variables (gelatin, carrageenan and alanine concentrations) on the 
crucial responses of the formulation (disintegration time, 
hardness, viscosity and pH). 
Face 
centered 
central 
composite 
design 
The disintegration time and viscosity were controlled by the 
associative interaction between gelatin and carrageenan upon 
hydration which forms a strong complex that increases the 
viscosity of the stock solution and forms tablet with higher 
resistance to disintegration in aqueous medium. 
Therefore, the levels of carrageenan, gelatin and their 
interaction in the formulation were observed to be the 
significant factors.  
21 
6 
Delayed 
Release Multi 
Particulates 
System 
Studies were performed to elucidate the effect of formulation 
variables i.e. amount of eudragit polymer, surfactant 
concentration and agitation speed on in-vitro release profiles, drug 
entrapment efficiency and particle size of multi-particulates 
system of indomethacin. 
Face 
centered 
central 
composite 
design 
It was found that in-vitro release was decreased significantly 
with increase in amount of eudragit polymer but increased 
significantly with increase in surfactant concentration and 
stirring speed. Finally, the results of response surface linear 
model were evaluated by Design Matrix analysis techniques. 
Further FDS graph was considered to check the linearity of 
model. 
22 
7 
Extended 
release matrix 
tablets 
A face-centered central composite design (26 runs 13 center 
points) was selected and the variables studied were filler ratio 
(lactose: dicalcium phosphate (50:50), polymer level 
(15/32.5/50%), magnesium stearate level (1/1.5/2%), lubricant 
blend time (2/6/10 min) and compression force (400/600/800 kg). 
Responses studied included percent drug released at 1,4, 6 and 
12hr 
Face 
centered 
central 
composite 
design 
Analysis of variance indicated that percent metoprolol 
release was found to be significantly reduced by an increase 
in polymer level from 10 to 50%. Increase in lactose level 
was found to increase release at 4, 6 and 12 h. Magnesium 
stearate and lubricant blend time main effects were not found 
to be statistically significant. Interactions between 
magnesium stearate and lubricant blend time, filler ratio and 
polymer level were found to be statistically significant. 
23 
8 
Solid lipid 
nanoparticles 
A two-factor, five-level CCD was applied to explore the optimum 
levels of independent variables such as Amount of lipid (% w/v) 
and drug/lipid ratio (%nw/w). Physicochemical properties of the 
Solid lipid nanoparticles, i.e. entrapment efficiency, particle size 
and Polydispersity index were selected as dependent variables. 
Central 
composite 
design 
Quantitative estimation of the significant models showed that 
lipid concentration and ratio of drug to lipid had the 
influence on the entrapment efficiency and particle size 
suggesting that increasing the amount of lipid and ratio in the 
formulation increased the entrapment efficiency and particle 
size of solid lipid nanoparticles. However for polydispersity 
index there is no impact of drug/polymer ratio. 
24 
9 Nanoparticles 
The independent variables considered for the optimization of 
camptothecin nanoparticles were percentage of camptothecin in 
raw material, concentration of camptothecin in working liquid, 
cycles numbers and homogenizer pressure for responses as drug 
loading efficiency, particle size and polydispersity index. 
Central 
composite 
design 
The effect of percentages of camptothecin and concentration 
of camptothecin on drug loading efficiency showed the linear 
relationship. At smaller concentration of camptothecin, 
particle size increase with the increase in percentages of 
camptothecin. However, particle size slightly decreases with 
the increase in percentages of camptothecin when 
concentration of camptothecin is higher. However, numbers 
25 
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of cycles and pressure of the homogenizer on particle size 
shows opposite effect. polydispersity index decrease at first 
with the increase of camptothecin percentages and increase 
at the end. 
S. 
No. 
Delivery 
System 
Details of Study Design Type Inference Ref. 
10 
Self-
emulsifying 
drug delivery 
system 
A three level Box Behnken design applied to investigate effect of 
independent variables as ratio surfactants/oil, cosurfactant / 
surfactant and percentage of cosolvent. The responses chosen 
were droplet size and cumulative percentage drug released in 20 
min 
Box 
Behnken 
design 
It was concluded that droplet size was significantly affected 
by the antagonistic effect of ratio of cosurfactant/surfactant, 
the interaction between the amount of cosolvent and the ratio 
cosurfactant/surfactant. Further drug release at 20min 
increases by low levels of ratio of co surfactant/ surfactant. 
26 
11 
Extended-
release matrix 
tablets 
3-factor, 3-level Box–Behnken statistical design studied 
considering independent variables as  the amount of 
hydroxypropyl methylcellulose (K4M), sodium alginate  and 
microcrystalline Responses studied included percent drug released 
at 2,4, 8,14 and 24hr. 
Box 
Behnken 
design 
IT was concluded that the effect of combination of 
hydroxypropyl methylcellulose (K4M) and sodium alginate 
was the most influencing factors on the drug release from 
extended release matrix tablets. The mechanism of drug 
release from ER tablets was dependent on the added amount 
of Sodium alginate. 
27 
12 
Solid Lipid 
Nano-particles 
Independent variables (factors) studied were drug to lipid ratio, 
surfactant concentration and stirring speed on dependent variables 
(responses) i.e. particles size, entrapment efficiency, and drug 
loading. 
Box 
Behnken 
design 
An increase in particle size was observed on increasing the 
drug to lipid ratio and vice versa for surfactant concentration 
(up to certain limit) and stirring speed. 
An increase in % entrapment efficiency was observed on 
increasing the drug lipid ratio and opposite effect observed 
for surfactant concentration and stirring speed. The effect of 
drug to lipid ratio on % drug loading is concentration 
dependent. A decrease in % drug loading was observed on 
increasing the drug to lipid ratio while stirring speed also 
showed positive effect on % drug loading. 
28 
13 
Controlled 
release tablets 
Studies were performed to evaluate the main and interaction 
effects of de-aggregating agent concentration, compression 
pressure and amount of precipitating water on naproxen release, 
thickness and hardness of tablets and yield and angle of repose of 
microspheres. 
Box 
Behnken 
design 
All three factors showed antagonistic effect on drug release 
i.e. increase in compression pressure affects the integrity of 
the resultant microspheres from which the tablets are 
prepared, resulting in increasing hardness of the tablets and, 
hence, the amount of drug dissolved was found to be 
decreased. 
29 
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B. FACTORIAL DESIGNS 
Optimization with factorial designs is a powerful, efficient and systemic tool that shortens the time required for the 
development of pharmaceutical dosage forms and improves research and development work. 
Various examples of studies using factorial designs are given in Table 4 along with details of study, design type and 
Inference of statistical optimization.  
C. D- OPTIMAL DESIGNS 
The most popular criterion in custom designs is d-optimality. D-optimal designs are based on principle minimization of 
variance and covariance of parameters. Unlike traditional designs, D-optimal designs do not require orthogonal design 
matrices, and as a result, parameter estimates may be correlated. 
Various examples of studies using D-optimal designs are given in Table 5 along with details of study, design type and 
Inference of statistical optimization.  
D. PLACKETT–BURMAN EXPERIMENTAL DESIGN 
Plackett–Burman experimental design (PB), which, a widely used and efficient screening design for the identification 
of “main factors” that cause variability in product quality. These designs commonly used in order to isolate the most 
important factors, to be used at their optimal level and the best responses to be achieved; a lot of experiments must be 
performed, including all the possible combinations between the different factors. The advantage of the PB design is that 
many factors can be screened with a relatively few number of trials. The disadvantage of these designs is that 
interactions between variables are generally confounded and cannot be easily determined, as there are not enough 
degrees of freedom. Also, unless treatments are replicated, variability cannot be evaluated. While these are significant 
limitations, when a large number of studies would be needed to implement higher-resolution factorial designs, the 
Plackett–Burman can be a pragmatic solution [42, 43]. 
Various examples of studies using Plackett–Burman experimental designs are given in Table 6 along with details of 
study, design type and Inference of statistical optimization.  
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Table 4. Examples of Studies using Factorial Design 
S. 
No. 
Delivery 
System 
Details of Study 
Design 
Type 
Inference Ref. 
14 
Multiparticulate 
system 
The studied factors (independent variables) were Eudragit 
S100: Eudragit L100 ratio and coating level. The dependent 
variables were lag time (the time required for drug release 
up to 2%) at pH 6.8 and percent of drug release at pH 6.8 in 
5 h. 
3
2 
full  
Factorial 
designs 
The results of study revealed that factorial design is a suitable tool for 
optimization of coating formulations to achieve colon delivery. It was shown 
that coating formulation consisted of Eudragit S100: Eudragit L 100 in 4:1 
ratio at 20% coating level has potential for colonic delivery of indomethacin 
loaded pellets. 
30 
15 
Controlled 
release 
microspheres 
Influence of three variables were studied as the stirring 
speed, concentration of CaCl and % of heavy liquid 
paraffin in a blend of heavy and light liquid paraffin in the 
dispersion medium on the response as time for 80% drug 
dissolution. 
3
3
 full 
factorial 
design 
The results of multiple linear regression analysis and F-statistics revealed 
that for obtaining controlled drug release, the microspheres should be 
prepared using relatively lower stirring speed, higher concentration of CaCl 
and higher percentage of heavy liquid paraffin in the dispersion medium. 
31 
16 
Mouth 
dissolving 
tablets 
The two independent factors, concentration of Indion-234 
and concentration of camphor were selected with three 
different levels to evaluate response variables as 
disintegration time, friability, and percent drug release. 
3
2 
full 
Factorial 
designs 
Study reveled that the use of superdisintegrant in higher concentration and 
camphor in lower concentration results in faster disintegration of the tablets, 
faster release with low friability. 
32 
17 
Controlled 
release tablets 
The three level factor corresponds to the three HPMC 
viscosity grades of 100, 4000 and 15,000 mPa s 
respectively. The two level factor corresponds to either 
water and fasted state dissolution media at same dip speed 
(10 dpm) or water and fed state dissolution media at same 
dip speed (15 dpm) The dependant variable for the 
statistical analysis of tablet erosion was derived as the 
erosion rate (Ker) (%/h). 
3
2 
full 
Factorial 
designs 
 
Dip speed has negligible effect on release and erosion rates. Using fasted 
media instead of water slightly decreases caffeine release from 100 and 4000 
mPa HPMC viscosity tablets as well as erosion rates, while 15,000mPa 
tablets remain unaffected. Fed compared to fasted media decreases caffeine 
release rate, and the food effect is greater for the 100mPa viscosity tablets 
compared to the 4000and 15,000mPa viscosity tablets. The investigation 
using texture analysis indicates that Ensure Plus® becomes rate-limiting for 
caffeine release from HPMC tablets by forming hydrophobic barrier around 
the tablets. The barrier decreases tablet water permeation, which decreases 
erosion rate in 100mPa viscosity tablets, swelling in 15,000 mPa viscosity 
tablets and caffeine release from both tablets. 
33 
18 
Gastric floating 
drug delivery 
system 
Independent variables evaluated included different ratios of 
HPMC K4M and K100LV, and absence or presence of 
CP934. Dependent variables studied included release 
parameters, i.e. calcium release at 6 h, time for the release 
of 50% of calcium (T50%) and floating properties, i.e. area 
under floating kinetics curve, and residual floating force. 
3
2 
full 
Factorial 
designs 
The decrease in the release rate was observed with an increase in the 
viscosity of the polymeric system. 
Polymer with lower viscosity (HPMC K100LV) was shown to be beneficial 
than higher viscosity polymer (K4M) in improving the floating properties of 
delivery system. Incorporation of Carbopol, however, was found to 
compromise the floating capacity of delivery system and release rate of 
calcium. 
34 
19 Buccal tablet 
The four compactor parameters that were to be optimized 
for the tablet properties were the compaction force, the gap 
between the rolls, the roll surface and the sieve aperture. 
 
2
4 
full 
Factorial 
designs 
 
From the tablet strength results, low compaction force, smooth rolls and 
large gap was preferred. From the dissolution profile and the bio-adhesive 
characteristic results, high compression pressure, ribbed rolls and small sieve 
aperture was preferred. Smooth roll was optimal for tablet strength, but 
ribbed roll was optimal for the dissolution profile. As the dissolution profile 
was considered more important than tablet strength, ribbed rolls was chosen 
as optimal for the buccal tablet characteristics. 
35 
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Table 5. Examples of Studies using D-optimal design 
S. 
No. 
Delivery 
System 
Details of Study 
Design 
Type 
Inference Ref. 
21 
Controlled 
release Matrix 
tablet 
Influence of three formulation variables were studied as 
fraction of hydroxypropyl methylcellulose, fraction of sodium 
carboxymethylcellulose and Fraction of propranolol HCl and 
dependent variables were cumulative percents of drug 
released after 1, 6 and 12 h sampling intervals 
D-optimal 
design 
The results enabled the formulation of tablets with the desired dissolution 
characteristics together with a fairly complete characterization of the 
system. Optimization of release rate was performed applying constraints on 
the cumulative amounts of drug released after 1, 6 and 12 h release time 
intervals. Optimized formulations presented release rates that were close to 
the predicted values. 
36 
22 
Controlled 
release Matrix 
tablet 
The effects of the type of pectin as an amidated pectin and 
calcium salt of a high methoxylated pectin, the addition of 
ethylcellulose, the use of ethanol were evaluated with respect 
to responses such as hardness, Cumulative percentage of the 
drug released after 60 min (in SGF), 240 min (total amount 
released prior to the exposure to the enzymes) and 330 min (a 
point on the release curve in SCF where the whole dose has 
not yet been released). 
D-optimal 
design 
Amidated pectin produced harder tablets than the calcium salt of pectin and 
was more susceptible to enzymatic degradation. Addition of ethylcellulose 
increased the tablet strength and the dissolution rate. Furthermore, directly 
compressed Amidated pectin tablets were produced by addition of coarse or 
micronised qualities of ethylcellulose. 
37 
23 
Solid 
dispersion 
The factors considered from D-optimal mixture design were 
itraconazole fraction (20% - 50% w/w) HPMC and HP-β-CD 
fractions (10% w/w and 60% w/w). The responses chosen 
were clear extrudates, the torque, glass transition temperature 
and the apparent itraconazole solubility in 0.1 N HCl. 
D-optimal 
design 
mixture 
The results of study revealed that High itraconazole fraction in the mixture 
promoted a better melt processing (minimizes torque). High HPMC 
fraction (>33% w/w) resulted in clear extrudates, indicating a solid 
dispersion and resulted in high glass transition temperature of the melt. 
High HP-beta-CD fraction resulted in increased apparent itraconazole 
solubility in 0.1 N HCl. The optimal itraconazole formulation consisted of 
45% w/w HPMC and 15% HP-beta-CD w/w. 
38 
24 
Extended-
release matrix 
tablets 
The formulation variables investigated were applied 
compression force, granulometric fraction of Eudragit and 
Ethocel, drug content (%) and Eudragit–Ethocel ratio (%). 
Response variables variables considered were concentration 
of didanosine released after 60, 180, 360 min (% w/w), 
Dissolution efficiency at 360 min (%) and time to dissolve 
10% of drug. 
D-optimal 
design 
From study it was observed that, the drug content and the polymers ratio 
had the most important effect on drug release, moreover, was favored by 
greater polymers particle size; on the contrary the compression force did 
not have a significant effect. 
39 
25 Gene Delivery 
Formulation independent variables considered were pH, ionic 
strength, temperature, viscosity of the aqueous solutions, 
polymer/plasmid ratio and the presence of stabilizers for 
colloidal systems which affect the size of polymer/plasmid 
complexes 
D-optimal 
design 
From screening design, it was observed that at a fixed concentration of 
plasmid (40 μg/ml) after incubation with polymer, the size of the resulting 
polyplexes was highly dependent on the polymer/plasmid ratio as well as 
on the pH, viscosity (i.e. sucrose concentration) and ionic strength of the 
aqueous solution. However, the temperature, PEG 600 (up to 5% (v/v)) and 
Tween 80 (up to 0.2%) had a marginal effect on the size of the polyplexes. 
40 
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Table 6. Examples of Studies using Plackett Burnam design 
S. 
No. 
Delivery 
System 
Details of Study Design Type Inference Ref. 
26 Liposomes 
The author describes the application of Plackett burrnan 
design cosidering 11 important factors that are effective 
for stabilization of liposomal systems. Factors taken into 
consideration were 1) Free-complex 2) Oil red, 3) 
Oxybenzone, 4) Deoxybenzone, 5) Sulisobenzone, 6) 
Carotene, 7) DRV or MLV, 8) Cholesterol, 9) DSPC 10) 
Sonication time,  11) Sonication type. Stabilization ration 
was measured as dependent variable. 
Plackett Burnam 
design 
Results from studies showed that the most significant 
effect is the presence of the light absorber oil red O 
and the second most important factor is the complex 
with the cyclodextrin form of the vitamin. The third 
most important factor is the preparation method and 
indicates that the DRV is superior to that of MLV 
preparation method. The molar ratios of cholesterol as 
well as the presence of the rest light absorbers do not 
play an important role in the stabilization of vitamin. 
43 
27 
Osmotically 
controlled 
Gastrointestinal 
Therapeutic 
System 
The variables studied were orifice size, % coating weight 
gain, amounts of sodium chloride, Polyox N80 and 303, 
and Carbopol 934P and 974P on drug release.  The 
response variable considered is Cumulative percent of 
drug released in 24 hours 
Plackett Burnam 
design 
The design has revealed that orifice size, % coating 
weight gain and amount of Carbopolw 934P have 
prominent influence on in-vitro atenolol release. The 
results indicated that the drug release was influenced 
by the factors with decreasing order of importance as 
% coating weight gain) Carbopol 934P) olyox N80) 
Carbopol 974P) Polyox 303) amount of sodium 
chloride) orifice size. 
44 
28 
Immediate-
Release Tablets 
During study, different categoric and numeric factors were 
selected as  1)Disintegrant gelatinization 2)Tablet 
compression force 3) Speed of granulator after roller 
compaction 4)API particle size 5) Source/supplier of 
lubricant 6) Filler particle size 7) Binder grade 
(hydroxypropyl cellulose) 8) Ratio of roll speed to feed 
screw speed 9) Blending time 10) Glidant level 11) Roller 
pressure. 
The quality attributes of the tablet that were measured 
included: weight variation, tablet breaking force, 
disintegration time, and dissolution time . 
Plackett Burnam 
design 
It was observed that compression force and roller 
pressure were the most important parameters affecting 
tablet breaking force. Klucel® grade and Pmax were 
the most critical factors governing cipro release, i.e., 
disintegration and Q30 dissolution. In terms of granule 
properties (particle size, bulk density, and Carr index), 
roller pressure is critically affecting both particle size 
and the Carr Index. Mg stearate type and glidant level 
also affected particle size and the Carr index, 
respectively. 
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CONCLUSION 
It is important for a pharmaceutical scientist to use effective methodology to develop products in a timely manner 
without sacrificing quality. The use of DoE is a leading edge approach to optimization and screening of experimental 
parameters. Currently, it has gained acceptance as a pivotal developmental tool in diverse industrial processes. Current 
review is done considering the studies reported employing different types of statistical optimization. Key points while 
designing statistical optimization are choosing suitable responses (output variables) and factors (input variables), 
setting appropriate factor ranges or levels, managing the experimentation, interpreting numeric outcomes and graphic 
manifestations of the findings, presenting the results, and finally deciding whether to continue further with process 
optimization or just run confirmatory experiment(s) to validate DoE. Design of experiments will ultimately lead to 
scientific understanding about the product and resultant product will be robust with minimum processing issues and 
market withdrawals. 
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